Lincoln Pharmaceuticals fundamental analysis

LINCOLN

705.2

5.15 (-0.72%)
Last updated on 20 May, 2026 | 15:30 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Lincoln Pharmaceuticals Fundamentals

P/E Ratio

16.17

P/B Ratio

1.91

Div. Yield

0.25

Sector P/E

71.7

Sector P/B

3.51

Sec. Div. Yield

0.56

Lincoln Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 16.17, compared to the sector average of 71.7. Its P/B Ratio stands at 1.91, while the sector’s is 3.51. In terms of returns, the stock offers a Dividend Yield of 0.25%, which is than the sector’s 0.56%.

Lincoln Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Lincoln Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost